SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 146,720.17 |
Enterprise Value ($M) | 200,389.17 |
Book Value ($M) | 6,232.00 |
Book Value / Share | 11.62 |
Price / Book | 23.54 |
NCAV ($M) | -60,590.00 |
NCAV / Share | -112.96 |
Price / NCAV | -2.42 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.09 |
Return on Assets (ROA) | 0.08 |
Return on Equity (ROE) | 1.26 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.13 |
Current Ratio | 1.65 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 30,332.00 |
Assets | 97,154.00 |
Liabilities | 90,922.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 28,190.00 |
Operating Income | 13,399.00 |
Net Income | 6,717.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 8,471.00 |
Cash from Investing | -26,204.00 |
Cash from Financing | 21,048.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 9.16 | 2.02 | |
13G/A | State Street Corp | 5.52 | -0.73 | |
13G/A | BlackRock Inc. | 8.90 | -1.45 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
285,816 | 2,467,127 | 11.58 | |
430,488 | 1,094,235 | 39.34 | |
403,613 | 845,948 | 47.71 | |
777,694 | 1,291,463 | 60.22 | |
(click for more detail) |
Similar Companies | |
---|---|
ALNY – Alnylam Pharmaceuticals, Inc. | ALVR – AlloVir, Inc. |
ALXO – ALX Oncology Holdings Inc. | AMLX – Amylyx Pharmaceuticals, Inc. |
AMPH – Amphastar Pharmaceuticals, Inc. |